JonesTrading Maintains Perspective Therapeutics(CATX.US) With Buy Rating, Maintains Target Price $21

JonesTrading analyst Justin Walsh maintains $Perspective Therapeutics(CATX.US)$ with a buy rating, and maintains the target price at $21.According to TipRanks data, the analyst has a success rate of 3

Moomoo NewsJul 16 11:32 ET · Ratings

Buy Rating Affirmed for Perspective Therapeutics Amid Promising Radiopharmaceutical Advances

TipRanksJul 16 11:05 ET

Wall Street Analysts Think Perspective Therapeutics (CATX) Could Surge 80.31%: Read This Before Placing a Bet

Zacks Jul 16 09:05 ET

Express News | Perspective Therapeutics Inc : Jonestrading Adjusts Target Price to $21 From $2.2 to Reflect 1-for-10 Reverse Stock Split

ReutersJun 18 23:27 ET

JonesTrading Maintains Perspective Therapeutics(CATX.US) With Buy Rating, Cuts Target Price to $21

JonesTrading analyst Justin Walsh maintains $Perspective Therapeutics(CATX.US)$ with a buy rating, and adjusts the target price from $22 to $21.According to TipRanks data, the analyst has a success ra

moomoo NewsJun 18 13:32 ET · Ratings

Express News | Refile-Perspective Therapeutics : Oppenheimer Adjusts Target Price to $19 From $2 to Reflect 1-for-10 Reverse Stock Split (Clarifies PT Is Split-Adjusted)

ReutersJun 18 10:13 ET